HeartBeam, Inc. (BEAT) vs CervoMed Inc. (CRVO)

A side-by-side comparison of HeartBeam, Inc. and CervoMed Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

BEAT

HeartBeam, Inc.

$32M

$0.58HealthcareDelayed quote: Oct 6, 2026, 12:15 PM EDT

CRVO

CervoMed Inc.

$30M

$3.25HealthcareDelayed quote: Oct 6, 2026, 12:15 PM EDT

Total return — BEAT vs CRVO

growth of $100 · dividends reinvested · last 5y

BEAT -86.1% (-32.6%/yr)CRVO -90.0% (-36.9%/yr)BEAT compounded faster over this window

BEAT CRVO

BEAT vs CRVO: by the numbers

•BEAT is the larger company ($32M vs $30M market cap).
•Both run net losses; BEAT's is the smaller (0.00% vs -9408.76% net margin).

Metrics side by side

Valuation

Metric	BEAT	CRVO
P/S ratio	N/A	93.28
P/B ratio	3.94	1.31

Profitability

Metric	BEAT	CRVO
Gross margin	0.00%	0.00%
Operating margin	0.00%	0.00%
Net margin	0.00%	-9408.76%
ROE	-248.21%	-132.18%
ROIC	-249.58%	-135.73%

Growth (annualized)

Metric	BEAT	CRVO
Total return CAGR (5Y)	N/A	-38.25%

Go deeper

Full BEAT analysis Full CRVO analysis Interactive comparison tool

Dig into the metrics

HeartBeam ROE CervoMed ROE HeartBeam operating margin CervoMed operating margin HeartBeam revenue growth CervoMed revenue growth HeartBeam free cash flow CervoMed free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.